BBVA
FBIO icon

Banco Bilbao Vizcaya Argentaria’s Fortress Biotech FBIO Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,000
Closed -$80K – 708
2020
Q2 		$80K Hold
2,000
– – ﹤0.01% 740
2020
Q1 		$56K Hold
2,000
– – ﹤0.01% 665
2019
Q4 		$77K Buy
+2,000
New +$51.3K ﹤0.01% 706

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's FBIO Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Fortress Biotech (FBIO) in Q3 2020, closing a stake of 2,000 shares — an estimated $80K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in FBIO in Q4 2019 and held it in 3 quarters. The position peaked at $80K in Q2 2020. 77 funds tracked by Wall St. Rank hold FBIO as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Fortress Biotech position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 2,000 Fortress Biotech shares in Q3 2020, an estimated $80K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Fortress Biotech in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Fortress Biotech position peaked at $80K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.